Speaker

Kavita Swami

KSKavita Swami, All India Institute of Medical Sciences, Gorakhpur

Kavita Swami

All India Institute of Medical Sciences, Gorakhpur

India

About Kavita Swami

Dr. Kavita Swami is a postgraduate resident in Dermatology, Venereology, and Leprology at AIIMS Gorakhpur, India. Her special interests include pigmentary disorders, vitiligo, and dermoscopy. She has co-authored many publications in renowned dermatology journals, including work on cutaneous lymphoma and dermatologic surgery. Her postgraduate research focuses on targeted therapies for vitiligo, particularly a double-blind randomized controlled trial comparing topical tofacitinib and tacrolimus. She is also conducting an ongoing study investigating the role of dermoscopy in pediatric vitiligo. Her research interests center on improving diagnostic assessment, monitoring treatment responses, and advancing evidence-based management of pigmentary disorders.

Featured talk at IDC 2027

“Efficacy of 2% tofacitinib ointment versus 0.1% tacrolimus ointment in patients of vitiligo: A hospital-based, double-blinded, randomised controlled trial”

Introduction : The interferon-γ/JAK-STAT/CXCL10 signaling axis plays a central role in melanocyte destruction in vitiligo, providing a mechanistic rationale for targeted Janus…

Read the full abstract →
View in scientific program →

Join the IDC 2027 delegation

Rome · June 21–23, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.